Keywords: astrazeneca, files, faslodex, europe, filed, approval, market

AstraZeneca files Faslodex in Europe

Article | 17 February 2003

Print This

AstraZeneca has filed for approval to market its novel anti-estrogendrug Faslodex (fulvestrant) in the European Union for the treatment of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in